Differentiated thyroid cancer presenting with distant metastases: A population analysis over two decades

World Journal of Surgery

Volumn 37, Issue 7, 2013, Pages 1599-1605

  Goffredo, Paolo ^a   Sosa, Julie A ^b   Roman, Sanziana A ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER REGISTRY; FEMALE; HUMAN; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; STATISTICAL MODEL; SURVIVAL; THYROID TUMOR; THYROIDECTOMY; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT; THYROID NEOPLASMS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RADIOTHERAPY, ADJUVANT; SEER PROGRAM; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84879797330     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-013-2006-9     Document Type: Article

References (26)

1. Wartofsky L (2010) Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure? Hormones (Athens) 9:103-108
2. Nixon IJ, Whitcher M, Palmer FL et al (2012) The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland. Thyroid 22:884-889
3. Lee J, Soh EY (2010) Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors. Ann Surg 251:114-119
4. Sampson E, Brierley JD, Le LW et al (2007) Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer 110:1451-1456
5. Haq M, Harmer C (2005) Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol (Oxf) 63:87-93
6. Benbassat CA, Mechlis-Frish S, Hirsch D (2006) Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer. World J Surg 30:1088-1095. doi: 10.1007/s00268-005-0472-4
7. Shoup M, Stojadinovic A, Nissan A et al (2003) Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg 197:191-197
8. Mishra A, Mishra SK, Agarwal A et al (2002) Metastatic differentiated thyroid carcinoma: clinicopathological profile and outcome in an iodine deficient area. World J Surg 26:153-157. doi: 10.1007/s00268-001-0198-x
9. Shaha AR, Shah JP, Loree TR (1997) Differentiated thyroid cancer presenting initially with distant metastasis. Am J Surg 174:474-476
10. Casara D, Rubello D, Saladini G et al (1993) Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 34:1626-1631
11. Mizukami Y, Michigishi T, Nonomura A et al (1990) Distant metastases in differentiated thyroid carcinomas: a clinical and pathologic study. Hum Pathol 21:283-290
12. Ruegemer JJ, Hay ID, Bergstralh EJ et al (1988) Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 67:501-508
13. Mihailovic JM, Stefanovic LJ, Malesevic MD et al (2009) Metastatic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases. Nucl Med Commun 30:558-564
14. Cooper DS, Doherty GM, Haugen BR, The American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer et al (2009) Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
15. Gharib H, Papini E, Paschke R, AACE/AME/ETA Task Force on Thyroid Nodules et al (2010) American Association of clinical endocrinologists, associazione medici endocrinologi, and European thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. J Endocrinol Invest 33(5 Suppl):51-56
16. National Cancer Institute (2012) SEER: surveillance, epidemiology, and end results program. URL: http://seer.cancer.gov/. Accessed 17 Apr 2012
17. Fritz A, Percy C, Jack A et al (2000) In: Eng C international classification of disease for oncology, 3rd edn. IARC, Geneva
18. National Cancer Institute (2011) SEER research data record description. URL: http://seer.cancer.gov/data/seerstat/nov2011/TextData.FileDescription.pdf. Accessed 17 April 2012
19. National Cancer Institute (2009) SEER: surveillance, epidemiology, and end results program. URL: http://seer.cancer.gov/registries/index.html. Accessed 19 April 2009
20. National Cancer Institute. Staging information for thyroid cancer. URL: http://cancer.gov/cancertopics/pdq/treatment/thyroid/HealthProfessional/page3. Accessed 30 April 2012
21. National Cancer Institute (2012) SEER: Glossary of statistical terms. URL: http://seer.cancer.gov/cgi-bin/glossary/glossary.pl#letter-s. Accessed 29 April 2012
22. McNally RJ, Blakey K, James PW et al (2012) Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis. Eur J Epidemiol 27(8):615-622. doi: 10.1007/s10654-012-9710-x
23. Lin JD, Huang MJ, Juang JH et al (1999) Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. Thyroid 9:1227-1235
24. National Cancer Institute (2012) SEER: Surveillance, epidemiology, and end results program. SEER quality improvement. URL: http://seer.cancer.gov/qi/. Accessed 26 April 2012
25. Harlan LC, Hankey BF (2003) The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies. J Clin Oncol 21:2232-2233
26. Yu JB, Gross CP, Wilson LD (2009) NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park) 23:288-295